GVN Center and Member Spotlight – Matthew Frieman

By vgn1 | June 4, 2020 | Comments Off on GVN Center and Member Spotlight – Matthew Frieman

Members > Spotlights > Matthew Frieman GVN Center and Member Spotlight Matthew Frieman Associate Professor, The Department of Microbiology and Immunology; Associate Member of The Center for Vaccine Development and Global Health University of Maryland School of Medicine, USA   What are you and your institution currently working on regarding SARS-CoV-2? (One paragraph) My lab…

Read More

TWO CENTERS OF EXCELLENCE OF THE GLOBAL VIRUS NETWORK INDEPENDENTLY VERIFY AN ANTIMICROBIAL TECHNOLOGY THAT ERADICATES SARS-CoV-2 ON SURFACES FOR MORE THAN SIX WEEKS

By vgn1 | June 4, 2020 | Comments Off on TWO CENTERS OF EXCELLENCE OF THE GLOBAL VIRUS NETWORK INDEPENDENTLY VERIFY AN ANTIMICROBIAL TECHNOLOGY THAT ERADICATES SARS-CoV-2 ON SURFACES FOR MORE THAN SIX WEEKS

Global Virus Network Also Advances The Study Of The Oral Polio Vaccine As A Preventive Measure Against SARS-CoV-2 Baltimore, Maryland, USA, June 4, 2020:  The Global Virus Network (GVN), a coalition comprised of the world’s preeminent human and animal virologists from 53 Centers of Excellence and 10 Affiliates in 32 countries, announced that two of…

Read More

New Insights into the SARS-CoV-2 Vaccine

By vgn1 | June 2, 2020 | Comments Off on New Insights into the SARS-CoV-2 Vaccine

There has been some very interesting news in the last several days that relate to vaccine development. The first of these is a report of results on the Phase 1 trials of the Moderna mRNA vaccine.  Most importantly, the vaccine appeared to be safe; no major adverse events were reported. Vaccines developed binding antibodies to…

Read More